Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-β1 expression

Journal of Nutritional Biochemistry

Volumn 23, Issue 9, 2012, Pages 1080-1085

  Chen, Rong ^a,b   Xue, Jie ^b   Xie, Meilin ^b  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Myocardial fibrosis; Nuclear factor B; Peroxisome proliferator activated receptor ; Puerarin; Transforming growth factor 1

Indexed keywords

COLLAGEN; HYDROXYPROLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPRENALINE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PUERARIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEART; HEART MUSCLE FIBROSIS; HEART WEIGHT; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BIOLOGICAL AGENTS; CARDIOMYOPATHIES; CARDIOTONIC AGENTS; COLLAGEN; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FIBROSIS; HEART; HYDROXYPROLINE; ISOFLAVONES; ISOPROTERENOL; MALE; MICE; MICE, INBRED STRAINS; MYOCARDIUM; NF-KAPPA B; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RANDOM ALLOCATION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

MUS; PUERARIA MONTANA VAR. LOBATA;

EID: 84865063532     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.05.015     Document Type: Article

References (27)

1. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Therapeut 2009, 123:255-278.
2. Zhang R.Y., Wang L.F., Zhang L., Meng X.N., Li S.J., Wang W.R. Effects of angiotensin converting enzyme inhibitor, angiotensin II type I receptor blocker and their combination on postinfarcted ventricular remodeling in rats. Chinese Med J 2006, 119:649-655.
3. Galderisi M., de Divitiis O. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 2008, 51:523-531.
4. Triggle D.J. Calcium channel antagonists: clinical uses - past, present and future. Biochem Pharmacol 2007, 74:1-9.
5. Brouri F., Hanoun N., Mediani O., Saurini F., Hamon M., Vanhoutte P.M., et al. Blockade of β1-and desensitization of β2-adrenoceptors reduce isoprenaline-induced cardiac fibrosis. Eur J Pharmacol 2004, 485:227-234.
6. Kumar A., Meyerrose G., Sood V., Roongsritong C. Diastolic heart failure in the elderly and the potential role of aldosterone antagonists. Drugs Aging 2006, 23:229-308.
7. Wu X.P., Feng J.G., Chen H.M., Cheng F., Zhang L., Wei Z., et al. Protective effects of puerarin against myocardial injury in patients with hypertension during perioperational period. Chin J Inte Trad West Med (Chinese) 2006, 26:255-257.
8. Wang Q., Wu T., Chen X., Ni J., Duan X., Zheng J., et al. Puerarin injection for unstable angina pectoris. Cochrane Database Syst Rev 2006, 3:CD004196.
9. Zhang S., Chen S., Shen Y., Yang D., Liu X., Sunchi A.C., et al. Puerarin induced angiogenesis in myocardium of rat with myocardial infarction. Biol Pharm Bull 2006, 29:945-950.
10. Mezei O., Banz W.J., Steger R.W., Peluso M.R., Winters T.A. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 2003, 133:1238-1243.
11. Yuan J., Wu J., Huanf Z.G., Zhong X.K., Zhou L.W., Yu B. Role of peroxisome proliferator-activated receptor α activation in acute myocardial damage induced by isoproterenol in rats. Chinese Med J 2008, 121:1569-1573.
12. Blanquart C., Barbier O., Fruchart J.C., Staels B., Glineur C. Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol 2003, 85:267-273.
13. Kim D.J., Murray I.A., Burns A.M., Gonzalez F.J., Perdew G.H., Peters J.M. Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity. J Biol Chem 2005, 280:9519-9527.
14. Diep Q., Benkiran K., Amiri F., Cohn J.S., Endemann D., Schiffrin E.L. PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats. J Mol. Cell Cardiol 2004, 36:295-304.
15. Ogata T., Miyauchi T., Sakai S., Takanashi M., Irukayama T.Y., Yamaguchi I. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway. J Am Coll Cardiol 2004, 43:1481-1488.
16. Iglarz M., Touyz R.M., Viel E.C., Paradis P., Amiri F., Diep Q.N., et al. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension. Hypertension 2003, 42:737-743.
17. Shiomi T., Tsutsui H., Hayashidani S., Suematsu N., Ikeuchi M., Wen J., et al. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2002, 106:3126-3132.
18. Zhang S.H., Ji G., Liu J.W. Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin. J Nutr Biochem 2006, 17:485-491.
19. Liu S.Y., Wang M.H., Zheng Z.Q., Peng J.T., Peng X.P., Fu Y.N. Puerarin decreases isoprenaline induced myocardial fibrosis and expression of connective tissue growth factor in myocardial tissue of rats. J Clin Cardiol (Chinese) 2008, 24:682-685.
20. Li M., Zhang J., Chen Y., Wang Y.Q. Danshen inhibiting isoproterenol induced cardiac hypertrophy and fibrosis in mice and its mechanisms. J China Pharm Univ (Chinese) 2003, 34:565-568.
21. Fishbein M.C., Maclean D., Maroko P.R. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 1978, 90:57-70.
22. Leask A., Abraham D.J. TGF-beta signaling and the fibrotic response. FASEB J 2004, 18:816-827.
23. Rosenkranz S. TGF-β1 and angiotensin networking in cardiac remodeling. Cardiovas Res 2004, 63:423-432.
24. Dostal D.E., Booz G.W., Baker K.M. Regulation of angiotensinogen gene expression and protein in neonatal rat cardiac fibroblasts by glucocorticoid and β-adrenergic stimulation. Basic Res Cardiol 2000, 95:485-490.
25. Bowie A., O'Neill L.A. Oxidative stress and nuclear factor kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000, 59:13-23.
26. Chen X.F., Lei K.F., Dong M., Fang Z.X., Jin L.Q. Effect of puerarin on myocardial damage in STZ-induced diabetic rats. Chin J Pathophysiol (Chinese) 2010, 26:650-655.
27. Lee O.H., Seo D.H., Park C.S., Kim Y.C. Puerarin enhances adipocyte differentiation, adiponectin expression, and antioxidant response in 3T3-L1 cells. Biofactors 2010, 36:459-467.